Health

Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting

- Ascletis to present data from the U.S. Phase Ib clinical study of ASC30 oral tablet in oral discussion - On track to report topline data from Phase IIa clinical study of ASC30 oral tablet in participants with obesity or overweight in the fourth quarter of 2025 HONG KONG, Sept. 2, 2025 /PRNe...

2025-09-02 18:00 1367

Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights

SHANGHAI, Sept. 2, 2025 /PRNewswire/ -- Peptides have recently emerged at the forefront of therapeutic innovation, with cyclic peptides gaining particular attention for their ability to bridge the gap between small molecules and large biologics. Positioned between the two, cyclic peptides combine...

2025-09-02 17:52 1301

Nuffield Holdings Welcomes Strategic Shareholders to Drive Next Phase of Regional Growth

Capital injection to accelerate M&A, AI-led operations, and expansion across Southeast Asia and the Middle East. SINGAPORE, Sept. 2, 2025 /PRNewswire/ -- Nuffield Holdings  is pleased to announce the appointment of MrLiu Song and Ms Zhang Na as new shareholde...

2025-09-02 16:45 2547

Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy

HONG KONG, Sept. 2, 2025 /PRNewswire/ -- Akeso (9926.HK) has recently announced the completion of patient enrollment in its Phase III, multicenter, randomized, controlled, registrational study evaluating ivonescimab, in combination with standard therapy, against durvalumab (PD-L1) combination the...

2025-09-02 16:00 1335

Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL

 – establishing U.S. manufacturing footprint – BASEL, Switzerland, Sept. 2, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality, sustainable ingredients from natural sources, announced today the signing of a binding and definitive agreement to acquire the multipurpose production ...

2025-09-02 15:00 1661

Heartbeats: 230,000 Views for Dr. Kiat's Everyday Lunch - A Viral Lesson That Science Has No Borders

SYDNEY, Sept. 2, 2025 /PRNewswire/ -- A humble lunch video from world-renowned cardiologist Dr. Hosen Kiat has captured more than 230,000 views on Chinese social media Little Red Book. Shared as part of his new digital wellness initiative with Heartbeats, the "real-style" post featured nothing mo...

2025-09-02 10:08 1328

SteriLance Safety Lancets Adopted Across Thailand's Public-Hospital Channels

BANGKOK, Sept. 2, 2025 /PRNewswire/ -- SteriLance Medical announced that its safety lancet portfolio — PRESS PLUS, IMPRESS and LITE3 — has been adopted withinThailand's public-hospital channels following a tender awarded by a nationally recognized humanitarian organization. Supply and post-market...

2025-09-02 08:59 1806

LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company

Secures third contract this year, reinforcing global competitiveness and expanding strategic partnerships SEOUL, South Korea and SYRACUSE, N.Y., Sept. 2, 2025 /PRNewswire/ -- LOTTE BIOLOGICS (CEOJames Park) today announced that it has entered a late-stage to commercial contract manufacturing par...

2025-09-02 08:00 1144

AMI Pharm's AYP-101 Shows Promise in Phase 2 Trial, Signaling a Breakthrough in Nonsurgical Fat Reduction

* AMI Pharm's 'AYP-101' Sets to Become a New Leader in Nonsurgical Fat Reduction with Phase 2 Trial Success * 'AYP-101,' a Promising Nonsurgical Solution, Has Its Clinical Results Published in Clinical Therapeutics * 'AYP-101' Demonstrates Superior Safety and Efficacy, Poised to Change the ...

2025-09-01 21:00 1438

Norma Completes Quantum AI Algorithm Validation on NVIDIA

"Quantum AI up to 73x Faster on NVIDIA CUDA-Q" * Norma, a quantum computing company, has validated the performance of quantum AI algorithms using NVIDIA CUDA-Q. * By running these algorithms for drug development on CUDA-Q, Norma observed computational speeds up to 73 times faster. * The com...

2025-09-01 21:00 1706

Introducing FitTransformer: The World's First Modular Smart Gym That Transforms Your Home Workouts

PHOENIX, Sept. 1, 2025 /PRNewswire/ -- Today marks the official launch of FitTransformer , a revolutionary fitness brand redefining how people train at home. Combining cutting-edge engineering, space-saving design, and intelligent performance tracking, FitTransformer ...

2025-09-01 16:00 1765

Data4Life announces the appointment of Dr. Ben Illigens as new CEO by the Hasso Plattner Foundation

POTSDAM, Germany, Sept. 1, 2025 /PRNewswire/ -- Data4Life announces that the Hasso Plattner Foundation, as the supporting foundation of the organization, has appointed Dr. Ben Illigens as its new Chief Executive Officer (CEO). He succeedsChristian Weiss, who has shaped the development phase of D...

2025-09-01 16:00 2690

Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches

ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to reverse remodel and recover from Heart Failure. After a successful First-In-Human study in 2019 followed by sustaining long-term results and a successful Randomized Contr...

2025-09-01 15:00 1350

Rosti to Showcase Next-Generation Medical Manufacturing Solutions at MedTec China 2025

SHANGHAI, Sept. 1, 2025 /PRNewswire/ -- Shanghai, September 24–26, 2025 – Stand 1D402 Rosti Integrated Manufacturing Solutions (Suzhou) Co., Ltd., part of the Rosti Group, will highlight its expanding medical device capabilities at MedTec China 2025, showcasing advanced medical injection mouldin...

2025-09-01 14:53 1581

CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry

GUANGZHOU, China, Sept. 1, 2025 /PRNewswire/ -- The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is set to take place from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) inGuangzhou. Themed "Health, Innovation, Collaboration," ...

2025-09-01 13:06 3866

Jenscare, releases 2025H1 interim results

BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs, achieved milestones in its product portfolio globally, and just released its interim results for 2025H1 endedJune 30, 2025...

2025-09-01 13:00 4893

AbbVie Named to 2025 Best Workplaces in Asia List by Great Place To Work

SINGAPORE, Sept. 1, 2025 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture, has selected AbbVie for the2025 Best Workplaces in Asia™ List , ranking the company No. 7 up from No. 8 last year.

2025-09-01 09:00 1534

Jenscare Announces 2025H1 Interim Results

BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases, achieved key milestones in its product portfolio and just announced its interi...

2025-09-01 09:00 5661

The Veteran Suite partners with QENDO to advocate for female veteran care

SYDNEY, Sept. 1, 2025 /PRNewswire/ -- The Veteran Suite, a medical centre exclusively for Australian veterans and their families, has launched a new partnership with QENDO, an Australian organisation providing support and education for those affected by endometriosis, adenomyosis, PCOS, infertili...

2025-09-01 08:00 1331

LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

HONG KONG, Aug. 30, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral ...

2025-08-30 01:07 5946
1 ... 55565758596061 ... 873

Week's Top Stories